Reset filter
Keywords
Gynecology ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
    1. 1.1. Eligibility Determination
    1. 1.2. Medical History
    1. 1.3. Physical Examination
    1. 1.4. Assessment Score
    1. 1.5. Apparative Diagnostics
    1. 1.6. Laboratory
    1. 1.7. Pathology/Histology
    1. 1.8. Consent
    1. 1.9. Therapy
    1. 1.10. Operative Report
    1. 1.11. Adverse Event
    1. 1.12. Follow-Up
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

1051 Search results.
Relevance Rating New first Old first

Eligibility Breast Cancer NCT00818051

- 9/27/21 - 1 form, 1 itemgroup, 20 items, 1 language
Itemgroup: Criteria
Radiation Therapy in Treating Women Who Have Undergone Breast Conservation Surgery and Systemic Therapy for Early Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00818051

Eligibility Metastatic Breast Cancer NCT01044485

- 9/27/21 - 1 form, 2 itemgroups, 20 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01044485

Eligibility Metastatic Breast Cancer NCT02394496

- 9/27/21 - 1 form, 2 itemgroups, 28 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Overcoming Endocrine Resistance in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02394496

Eligibility Breast Cancer NCT01069211

- 9/27/21 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Clinical Outcomes After Letrozole Treatment According to the Estrogen Receptor Expression in Postmenopausal Women; ODM derived from: https://clinicaltrials.gov/show/NCT01069211

Eligibility Breast Cancer NCT01067976

- 9/27/21 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI; ODM derived from: https://clinicaltrials.gov/show/NCT01067976

Eligibility Breast Cancer NCT00917735

- 9/27/21 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Green Tea and Reduction of Breast Cancer Risk; ODM derived from: https://clinicaltrials.gov/show/NCT00917735

Eligibility Breast Cancer NCT01013337

- 9/20/21 - 1 form, 1 itemgroup, 18 items, 1 language
Itemgroup: Criteria
Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint Pain; ODM derived from: https://clinicaltrials.gov/show/NCT01013337

Eligibility Breast Cancer NCT01917578

- 9/20/21 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction; ODM derived from: https://clinicaltrials.gov/show/NCT01917578

Eligibility Breast Neoplasms NCT00966043

- 9/20/21 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Prevalence of Genetic Polymorphisms in Genes Coding for Tamoxifen Metabolising Enzymes; ODM derived from: https://clinicaltrials.gov/show/NCT00966043

Eligibility Neoplasms, Breast NCT00790816

- 9/20/21 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents; ODM derived from: https://clinicaltrials.gov/show/NCT00790816

Eligibility Breast Cancer NCT02482376

- 9/20/21 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02482376

Eligibility Breast Cancer NCT02344940

- 9/20/21 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02344940

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial